The outcomes of our study aligned with a recent study that suggested that RES could alleviate kidney dysfunction induced by advanced glycation end-products via modulating the levels of inflammatory mediators, including cystatin c (Lan et al. 2023). The gene discussed is CST3; the disease is urogenital neoplasm.